Buck Institute Receives $21 Million Hevolution Foundation Grant

Multi-year Partnership Targeting Therapeutic Interventions in Aging

The Buck Institute for Research on Aging and the Hevolution Foundation have announced a novel multi-year partnership. This collaboration will pioneer new scientific initiatives and accelerate discoveries toward therapeutic interventions specifically targeting aging. The partnership centers on understanding and translating geroscience, a term coined at the Buck Institute, which is the interface between the biology of aging and age-related chronic diseases.

"We believe that human health is poised to be transformed through the translation of the last two decades of geroscience research," says Eric Verdin, MD, President and Chief Executive Officer of the Buck Institute. "Targeting the aging process will set us on the path to tackle the chronic diseases of aging such as Alzheimer's, Parkinson's, cancer, atherosclerosis (heart attacks and stroke), and type 2 diabetes. This generous multi-year $21 million grant from Hevolution is critical to our efforts."

The partnership will focus on three broad areas as the cornerstone for a future Healthspan Center for Translational Geroscience at the Buck Institute. Focused efforts will include discovering innovative therapeutic interventions for aging, identifying accurate biomarkers for measuring intervention effectiveness, and understanding environmental and lifestyle influences on healthspan and lifespan, known as the exposome.

"The Buck Institute is a world-renowned pioneer and global leader in aging research," says Dr. Mehmood Khan, Chief Executive Officer of the Hevolution Foundation. "This grant reflects Hevolution's unparalelled commitment to foster innovation in the field of healthspan science and shape a healthier aging future for all."

The announcement was unveiled at Hevolution’s inaugural Global Healthspan Summit, alongside other announcements for additional funding for AFAR, the American Federation for Aging Research, and for postdoctoral fellowships in Saudi Arabia which will support scientific discoveries targeting unhealthy aging.

About the Hevolution Foundation:

Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer. Connect with Hevolution Foundation on LinkedIn, X (formerly Twitter), and at hevolution.com